For: | Chen JF, Wu ZQ, Liu HS, Yan S, Wang YX, Xing M, Song XQ, Ding SY. Cumulative effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease in China. World J Gastroenterol 2024; 30(10): 1346-1357 [PMID: 38596503 DOI: 10.3748/wjg.v30.i10.1346] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v30/i10/1346.htm |
Number | Citing Articles |
1 |
Tsvetelina Velikova, Milena Gulinac. Novel insights into autophagy in gastrointestinal pathologies, mechanisms in metabolic dysfunction-associated fatty liver disease and acute liver failure. World Journal of Gastroenterology 2024; 30(27): 3273-3277 doi: 10.3748/wjg.v30.i27.3273
|
2 |
Wen-Xiu Liu, Lei Liu. Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction. World Journal of Hepatology 2024; 16(7): 990-994 doi: 10.4254/wjh.v16.i7.990
|
3 |
Yanyan Xuan, Dingting Wu, Qin Zhang, Zhiqiang Yu, Jingbo Yu, Dongdong Zhou. Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1457598
|
4 |
Patrizia Burra, Calogero Cammà, Pietro Invernizzi, Fabio Marra, Maurizio Pompili. Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases. Annals of Hepatology 2025; 30(1): 101900 doi: 10.1016/j.aohep.2025.101900
|
5 |
Changyan Zhu, Jiali Wu, Xiuyuan Wang, Weixing Zhang, Zhiqiang Fu, Yuqiu Hu. Analysis of influencing factors for achieving textbook outcome after laparoscopic right posterior sectionectomy of hepatocellular carcinoma. European Journal of Surgical Oncology 2025; 51(10): 110328 doi: 10.1016/j.ejso.2025.110328
|
6 |
Terence N Moyana. Metabolic dysfunction-associated steatotic liver disease: The question of long-term high-normal alanine aminotransferase as a screening test. World Journal of Gastroenterology 2024; 30(42): 4576-4582 doi: 10.3748/wjg.v30.i42.4576
|
7 |
Qihuan Yao, Guozhong Chen. Association of biochemical indicators with multimorbidity in 19,624 older adult individuals with chronic diseases: a study from Jindong District, Jinhua City, China. Frontiers in Public Health 2025; 13 doi: 10.3389/fpubh.2025.1472415
|
8 |
Amedeo Lonardo. Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!. World Journal of Gastroenterology 2024; 30(24): 3016-3021 doi: 10.3748/wjg.v30.i24.3016
|
9 |
Chen-Xiao Huang, Xiao-Dong Zhou, Calvin Q Pan, Ming-Hua Zheng. Screening for metabolic dysfunction-associated fatty liver disease: Time to discard the emperor’s clothes of normal liver enzymes?. World Journal of Gastroenterology 2024; 30(22): 2839-2842 doi: 10.3748/wjg.v30.i22.2839
|
10 |
Yanyan Tian, Yuhao Zhou, Wang Liao, Jiayue Xia, Qiaosheng Hu, Qing Zhao, Rui Zhang, Guiju Sun, Ligang Yang, Lihua Li. Flaxseed powder supplementation in non-alcoholic fatty liver disease: a randomized controlled clinical trial. Food & Function 2025; 16(4): 1389 doi: 10.1039/D4FO05847J
|
11 |
Di Wang, Bing-Yan Zhou, Lei Xiang, Xu-Yong Chen, Jie-Xiong Feng. Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease. World Journal of Gastroenterology 2024; 30(25): 3132-3139 doi: 10.3748/wjg.v30.i25.3132
|
12 |
Lívia da C. Agostini, Renata B. M. e Silva, Nayara N. T. Silva, Ana Cláudia F. Lopes, Vanessa de A. Belo, Wendel Coura-Vital, Luiz Fernando de M. Teixeira, Angélica A. Lima, Glenda Nicioli da Silva. The G allele of the rs4344 polymorphism of the angiotensin-converting enzyme gene is associated with alanine aminotransferase (ALT) and gamma glutamyl transferase (GGT) in Brazilian hypertensive patients. Molecular Biology Reports 2025; 52(1) doi: 10.1007/s11033-025-10386-6
|
13 |
Giovanna McGinty, Robert Przemioslo. Effects of excess high-normal alanine aminotransferase levels in relation to new-onset metabolic dysfunction-associated fatty liver disease: Clinical implications. World Journal of Gastroenterology 2024; 30(27): 3264-3267 doi: 10.3748/wjg.v30.i27.3264
|